Christian has three years of experience writing in the gaming industry, including guides and reviews, for publications such as Dualshockers, Attack of the Fanboy, and PC Invasion. He has been an avid ...

Tinder is looking to AI to revitalize its dating app, which has now reported nine straight quarters of paying subscriber declines, as of the third quarter this year. The dating app maker, Match Group, ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Add a Stop button directly in the API URL bar within Bruno, allowing users to immediately terminate a running request. During API testing or debugging, developers often need to cancel an ongoing ...

Elon Musk’s X, formerly known as Twitter, has introduced a new pay-per-use API model in an attempt to rebuild its once-thriving developer ecosystem. The platform, which previously charged flat monthly ...

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

X has announced a new pay-per-use self-serve API model in hopes of luring developers back to the platform. Credit: Gabby Jones/Bloomberg via Getty Images Good news! Elon Musk's X has heard the cries ...

Abstract: As modern web services increasingly rely on REST APIs, their thorough testing has become crucial. Furthermore, the advent of REST API documentation languages, such as the OpenAPI ...

San Bruno is foraying into an update for its historically beleaguered paid parking program with the mobile payment app ParkMobile — and councilmembers are urging precautions to make sure the rollout ...

The National Institutes of Health is continuing its mission to reduce the use of animals in drug testing by awarding $87 million in contracts to launch the Standardized Organoid Modeling (SOM) Center, ...

Immune cells can target cancer in the clinic. The ability to test a gene-editing technology in mice on a large scale should improve such immunotherapies. Michael Hudecek is in the Department of ...